Onconetix, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
ONCO$3.47-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current assets | ||
| Cash | $836,556 | $646,500 |
| Accounts receivable, net | 2,552 | 25,717 |
| Inventories | 151,556 | 64,079 |
| Prepaid expenses and other current assets | 311,362 | 213,971 |
| Total current assets | 1,302,026 | 950,267 |
| Property and equipment, net | 40,388 | 62,896 |
| Deferred offering costs | 150,000 | — |
| Operating right of use asset | 6,155 | 119,427 |
| Goodwill | 18,180,299 | 27,048,973 |
| Total assets | $19,678,868 | $28,181,563 |
| LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $1,804,163 | $3,787,564 |
| Accrued expenses | 476,289 | 888,988 |
| Notes payable, net of debt discount of $0 and $4,966 at September 30, 2025 and December 31, 2024, respectively | 160,267 | 9,328,061 |
| Operating lease liability, current | 6,155 | 119,427 |
| Subscription agreement liability – Related Party | — | 4,123,000 |
| Contingent warrant liabilities | 53,149 | 43,089 |
| Warrant liabilities | 12,815,000 | — |
| Derivative liabilities | 988,000 | — |
| Total current liabilities | 16,303,023 | 18,290,129 |
| Pension benefit obligation | - | 280,879 |
| Total liabilities | 16,303,023 | 18,571,008 |
| Commitments and Contingencies | ||
| Series C Redeemable Preferred Stock, $0.00001 par value, 10,000 shares authorized, 7 and 3,499 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 1,724 | 1,067,928 |
| Stockholders’ equity | ||
| Common stock, $0.00001 par value, 250,000,000 shares authorized at September 30, 2025 and December 31, 2024; 1,560,820 and 138,422 the shares issued at September 30, 2025 and December 31, 2024, respectively; 1,560,668 and 138,270 shares outstanding at September 30, 2025 and December 31, 2024, respectively | 15 | 1 |
| Series D Preferred Stock, $0.00001 par value, 32,000 and 0 shares authorized at September 30, 2025 and December 31, 2024, respectively; 16,325 and 0 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively. | — | — |
| Additional paid-in capital | 141,431,240 | 127,825,743 |
| Treasury stock, at cost; 152 shares of common stock at September 30, 2025 and December 31, 2024 | (625,791) | (625,791) |
| Due from shareholders | — | (250,308) |
| Accumulated deficit | (136,884,245) | (115,683,621) |
| Accumulated other comprehensive loss | (547,098) | (2,723,397) |
| Total stockholders’ equity | 3,374,121 | 8,542,627 |
| Total liabilities, convertible preferred stock, and stockholders’ equity | $19,678,868 | $28,181,563 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.